RENX Renalytix Plc

0.0705USD5.350 GBp · LSE0.00%Mkt Cap: 47.23M USDP/E: —

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs …

Institutional holders3 on file

Key Statistics

Company
Market Cap47.23M USD
Enterprise Value36.45M USD
Revenue (TTM)3.00M USD
Gross Profit1.20M USD
Net Income (TTM)-20.40M USD
Revenue/Share0.0070 USD
Last Price0.0705 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISINGB00BYWL4Y04
Valuation
P/E (Trailing)—
P/E (Forward)-0.59
PEG—
EV/EBITDA-2.02
EV/Revenue12.15
P/S11.96
P/B-5.12
EPS (TTM)-0.02 USD
EPS (Forward)-0.09 USD
52W Range
0.021162% of range0.1005
52W High0.1005 USD
52W Low0.0211 USD
Profitability
Gross Margin40.00%
Oper. Margin-463.33%
EBITDA Margin0.00%
Profit Margin-680.00%
ROE291.43%
ROA-334.43%
ROIC—
ROCE-1323.08%
Growth
Revenue Growth-17.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.90M USD
CapEx (TTM)—
FCF Margin-227.50%
FCF Yield-14.45%
Net Debt4.30M USD
Net Debt/EBITDA-0.31
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.19
Current Ratio0.61
Quick Ratio0.39
Book Value/Sh-0.01 USD
Cash/Share0.0030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.670.46M
Float312.15M
Insiders18.31%
Institutions46.64%
Technical
SMA 500.0755 (-6.7%)
SMA 2000.0455 (+54.9%)
Beta1.55
S&P 52W Chg12.00%
Avg Vol (30d)774.50K
Avg Vol (10d)330.72K
Technical Indicators
RSI (14)41.6
MACD-0.0515
MACD Signal-0.0300
MACD Hist.-0.0215
BB Upper0.0781 USD
BB Middle0.0727 USD
BB Lower0.0673 USD
BB Width14.79%
ATR (14)0.0041 USD
Vol Ratio (20d)1.00x

About Renalytix (LON: RENX)

›

Renalytix (LON: RENX) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Health Information Services industry, part of the Healthcare sector.

The shares were at 5.350 GBp on 19 November 2026, down 26.2% over 52 weeks. Its 52-week range is 1.600 GBp to 7.630 GBp: the price is 29.9% below the high and 234.4% above the low.

Its market capitalisation is 35.87M GBP.

Renalytix reports return on equity of 291.4%, an operating margin of -463.3% and revenue down 17.6% year over year.

Its debt exceeds its cash by 4.30M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.